Anti-CD32b/FCGR2B Antibody (2B6) is a human monoclonal antibody targeting CD32B. Anti-CD32b/FCGR2B Antibody (2B6) can be used for research on B-cell lymphoma [1].
In Vitro, Anti-CD32b/FCGR2B Antibody (2B6) is a human monoclonal antibody targeting CD32B, an IgG low-affinity inhibitory receptor and the major Fc receptor expressed on the surface of B cells, which is expressed in various B-cell malignancies[1].
References:
[1]. Rankin CT, et al. CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma. Blood. 2006;108(7):2384-2391.
In Vitro, Anti-CD32b/FCGR2B Antibody (2B6) is a human monoclonal antibody targeting CD32B, an IgG low-affinity inhibitory receptor and the major Fc receptor expressed on the surface of B cells, which is expressed in various B-cell malignancies[1].
References:
[1]. Rankin CT, et al. CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma. Blood. 2006;108(7):2384-2391.